p38α plays differential roles in hematopoietic stem cell activity dependent on aging contexts

Area of Science:

• Hematology
• Stem Cell Biology
• Molecular Biology
• Aging Research

Background:

• Hematopoietic stem cells (HSCs) are crucial for lifelong blood production.
• Aging negatively impacts HSC function, increasing risks for hematological malignancies.
• The precise molecular mechanisms driving HSC aging remain largely unknown.

Purpose of the Study:

• To investigate the role of p38 mitogen-activated kinase (p38MAPK) signaling in hematopoietic stem cell (HSC) aging.
• To elucidate the multimodal functions of the p38α isozyme in both chronological and premature aging models of HSCs.

Main Methods:

• Utilized genetic models simulating chronological and premature aging.
• Analyzed the impact of p38α modulation on HSC function, differentiation, and transplantation capacity.
• Examined HSC phenotypes in mice with combined deficiencies in p38α and ataxia-telangiectasia mutated (ATM).

Main Results:

• p38α initially supported HSC transplantation capacity and regulated differentiation bias during early chronological aging.
• In late-stage chronological aging, p38α diminished HSC transplantation capacity.
• Codeletion of p38α in ATM-deficient mice aggravated aging-related HSC defects.

Conclusions:

• p38α exhibits context-dependent roles in HSC aging, promoting and suppressing it at different stages.
• p38MAPK signaling is a key regulator of HSC aging and function.
• Findings offer new insights into the complex molecular mechanisms underlying HSC aging and its associated pathologies.